+ Site Statistics
References:
52,572,879
Abstracts:
28,705,754
PMIDs:
27,750,366
DOIs:
25,464,004
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections



Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections



Antimicrobial Agents and ChemoTherapy 60(4): 2265-2272



Increasing rates of fluoroquinolone resistance (FQ-R) have limited empirical treatment options for Gram-negative infections, particularly in patients with severe beta-lactam allergy. This case-control study aims to develop a clinical risk score to predict the probability of FQ-R in Gram-negative bloodstream isolates. Adult patients with Gram-negative bloodstream infections (BSI) hospitalized at Palmetto Health System in Columbia, South Carolina, from 2010 to 2013 were identified. Multivariate logistic regression was used to identify independent risk factors for FQ-R. Point allocation in the fluoroquinolone resistance score (FQRS) was based on regression coefficients. Model discrimination was assessed by the area under receiver operating characteristic curve (AUC). Among 824 patients with Gram-negative BSI, 143 (17%) had BSI due to fluoroquinolone-nonsusceptible Gram-negative bacilli. Independent risk factors for FQ-R and point allocation in FQRS included male sex (adjusted odds ratio [aOR], 1.97; 95% confidence intervals [CI], 1.36 to 2.98; 1 point), diabetes mellitus (aOR, 1.54; 95% CI, 1.03 to 2.28; 1 point), residence at a skilled nursing facility (aOR, 2.28; 95% CI, 1.42 to 3.63; 2 points), outpatient procedure within 30 days (aOR, 3.68; 95% CI, 1.96 to 6.78; 3 points), prior fluoroquinolone use within 90 days (aOR, 7.87; 95% CI, 4.53 to 13.74; 5 points), or prior fluoroquinolone use within 91 to 180 days of BSI (aOR, 2.77; 95% CI, 1.17 to 6.16; 3 points). The AUC for both final logistic regression and FQRS models was 0.73. Patients with an FQRS of 0, 3, 5, or 8 had predicted probabilities of FQ-R of 6%, 22%, 39%, or 69%, respectively. The estimation of patient-specific risk of antimicrobial resistance using FQRS may improve empirical antimicrobial therapy and fluoroquinolone utilization in Gram-negative BSI.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058595064

Download citation: RISBibTeXText

PMID: 26833166

DOI: 10.1128/AAC.02728-15


Related references

Fluoroquinolone use and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2008. Journal of Infection 64(6): 618-620, 2012

Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization. Clinical Microbiology and Infection 21(9): 843-849, 2016

Fluoroquinolone use and resistance of Gram-positive bacteria causing healthcare-associated infections. Journal of Antimicrobial ChemoTherapy 67(6): 1560-1562, 2012

In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections. Journal of Microbiology, Immunology, and Infection 40(6): 481-486, 2007

Bloodstream infections in a medical-surgical intensive care unit: incidence, aetiology, antimicrobial resistance patterns of Gram-positive and Gram-negative bacteria. Clinical Microbiology and Infection 15(10): 943-946, 2009

Rising problem of multidrug-resistant gram-negative bacteria causing bloodstream infections after liver transplantation: how should we handle the issue?. Liver Transplantation 16(10): 1217-1219, 2011

Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infections. Journal of Hospital Infection 76(4): 324-327, 2011

Antimicrobial resistance patterns of Gram-negative bacteria isolated from bloodstream infections in an Iranian referral paediatric hospital: A 5.5-year study. Journal of Global Antimicrobial Resistance 11: 17-22, 2017

Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections. Expert Review of Anti-Infective Therapy 3(6): 915-922, 2005

High burden of antimicrobial resistance among gram negative bacteria causing healthcare associated infections in a critical care unit of Nepal. Antimicrobial Resistance and Infection Control 6: 67, 2017

Bloodstream infections in pediatric patients with acute leukemia: Emphasis on gram-negative bacteria infections. Journal of Microbiology, Immunology, and Infection 50(4): 507-513, 2015

Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009. Journal of Antimicrobial ChemoTherapy 66(6): 1374-1382, 2011

Catheter-related bloodstream infections caused by Gram-negative bacteria. Journal of Hospital Infection 85(4): 316-320, 2014

Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections. Antimicrobial Agents and ChemoTherapy 61(3), 2016

Susceptibility in vitro to certain quinolines of gram-negative bacteria and gram-positive cocci causing urinary tract infections. Medycyna Doswiadczalna i Mikrobiologia 45(1): 115-118, 1993